← Eichor
Study identifier: NCT02208388 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial

Condition: Coronary Disease  ·  Sponsor: Young-Hak Kim, MD, PhD

PhaseNA
Planned participants1000
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate safety and effectiveness of CTP(computed tomography perfusion) guided revascularization vs FFR(Fractional flow reserve) guided revascularization

This description comes directly from the study's public registry record.

Talk to the study team

Young-Hak Kim, MD  ·  mdyhkim@amc.seoul.kr

Always discuss trial participation with your own doctor first.

Locations (7)

Asan Medical CenterSeoul, Songpa-Gu, South KoreaRecruiting
Hallym University Sacred Heart HospitalAnyang, South KoreaCompleted
Gangwon National Univ. HospitalChuncheon, South KoreaCompleted
Keimyung University Dongsan Medical CenterDaegu, South KoreaCompleted
Pusan National University HospitalPusan, South KoreaEnrolling By Invitation
Pusan National University Yangsan HospitalPusan, South KoreaCompleted
Severance HospitalSeoul, South KoreaWithdrawn

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02208388